Course Information

Release date: February 27, 2025
Expiration date: February 27, 2026
Estimated time to complete activity: 45 minutes

PROVIDER STATEMENT

This CME activity for ACCME and MOC credit is provided by Integrity CE, LLC.
This CE activity for ACPE and ANCC credit is jointly provided by Global Education Group and Integrity CE, LLC.

DISCLOSURE OF COMMERCIAL SUPPORT

This activity is supported by an educational grant from Salix Pharmaceuticals.

PROGRAM OVERVIEW

This video-based activity will discuss improving inpatient hospital care along with reducing rehospitalizations for patients with hepatic encephalopathy (HE). Our expert faculty will present current guideline recommendations to achieve accurate diagnosis and summarize clinical trial evidence regarding the efficacy and safety of therapies for treatment of acute episodes of overt HE and prevention of their recurrence. Transitional care strategies to prevent future hospitalizations among patients with HE will also be examined.

Learning Objectives

TARGET AUDIENCE

This educational initiative has been designed for hospitalists, general internists, subspecialists, and family practitioners caring for hospitalized patients.

LEARNING OBJECTIVES

Upon completion of this educational activity, participants should be able to:

Apply current guideline recommendations to achieve accurate diagnosis and improve the management of HE in hospitalized patients
Summarize current clinical trial evidence regarding the efficacy and safety of therapies for treatment of acute episodes of overt HE and prevention of their recurrence
Utilize evidence-based transitional care strategies to prevent future hospitalizations among patients with HE

Faculty Information and Disclosures

FACULTY

Jasmohan S. Bajaj, MBBS, MD, MS, FACG
Professor of Medicine
Division of Gastroenterology, Hepatology, and Nutrition
Virginia Commonwealth University
Richmond VA Medical Center
Richmond, Virginia

DISCLOSURE OF CONFLICTS OF INTEREST

Integrity CE, LLC and Global Education Group require instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any financial relationships with ineligible companies. All identified relevant financial relationships are thoroughly vetted by Integrity CE, LLC and Global Education Group for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. All relevant financial relationships have been mitigated. The following faculty/planners reported the relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of these CME activities:

Jasmohan S. Bajaj, MBBS, MD, MS, FACG
Research Grants: Bausch, Grifols, Mallinckrodt, Sequana

The Integrity CE, LLC and Global Education Group planners and managers do not have any relevant financial relationships or relationships to products or devices with ineligible companies.

Accreditation Information

DIRECTIONS TO LEARNER

There are no fees for participating and receiving CME credit for this activity. During the period of February 27, 2025 through February 27, 2026, participants must:

Read the learning objectives
Complete the pretest
Study the educational activity
Complete the posttest and the evaluation form

A statement of credit will be issued only upon receipt of a completed posttest with a score of 75% or better and a completed activity evaluation form. For pharmacist/ACPE learners, please check the CPE monitor for your CE credit within 60 days of the activity. Credit cannot be issued after 60 days.

ACCREDITATION

Physician Continuing Education

Integrity CE, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION

Integrity CE, LLC designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Nursing Continuing Education

Global Education Group is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

This educational activity for 0.75 contact hour including 0.0 pharmacotherapeutic contact hour is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacist Continuing Education

Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

Credit Designation

Global Education Group designates this continuing education activity for 0.75 contact hour (0.075 CEU) of the Accreditation Council for Pharmacy Education. (Universal Activity Number – 0530-9999-25-003-H01-P.)

This is a knowledge-based activity.

CONTACT INFORMATION

For information about ACCME accreditation of this activity, please contact Integrity CE, LLC at (855) 835-4004 or cme@integrityce.com. For information about ACPE or ANCC approval of this activity, please contact Global Education Group at (303) 395-1782 or cme@globaleducationgroup.com.

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity CE, LLC and Global Education Group do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimers and Technical Requirements

MEDIA

Internet

PRIVACY POLICY

When you participate in an online educational activity sponsored by Integrity CE, LLC, you will be asked for your name, degree(s), affiliation(s), street address, telephone number and…(continued)

MINIMUM SYSTEM REQUIREMENTS

Minimum Processor: Intel Pentium 4, 2.33 + GHz (or equivalent) Operating Systems: Windows XP, Windows 2000, Windows Vista, Windows 7, Windows 10, and Mac OS Plug-in: Adobe^® Flash^® Player 10

Adobe^® Flash^® Player 10 plug-in should be downloaded
Click on the “Agree and install now” button after unchecking the optional McAfee Security Scan Plus

For optimal performance, the use of Internet Explorer below 8 is not recommended For a full listing of recommended operating systems, browsers, and system configurations, please click on the link below: Click here for more information on minimum system requirements

DISCLAIMER

The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

Release date: February 27, 2025Expiration date: February 27, 2026Estimated time to complete activity: 45 minutes

Improving Inpatient Care and Reducing Rehospitalizations for Hepatic Encephalopathy